Science Videos
from news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Date:
July 21, 2014
Source:
TheStreet / Powered by NewsLook.com
Summary:
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Share:
         
Total shares:  
Related Videos
 

Share This Page:


Health & Medicine News
August 31, 2015

Latest Headlines
updated 12:56 pm ET